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Infections with high-risk human papillomaviruses
(HPVs) are associated with the vast majority of cervical
carcinoma. A fraction of other anogenital tract malignan-
cies such as penile cancer in males and vulvovaginal can-
cers in females as well as anal carcinomas in
immunosuppressed patients and some oropharyngeal
carcinomas are also associated with high-risk HPV infec-
tions. These cancers generally arise as a consequence of a
molecular accident whereby a small genomic high-risk
HPV fragment is irreversibly integrated into a host cell
chromosome resulting in dysregulated expression of the
HPV E6 and E7 oncogenes. Expression of HPV E6/E7 in
epithelial cells recapitulates key steps of cervical neoplasia
and cancer, which allowed for the creation of tissue cul-
ture and animal models of cervical cancer. High-risk HPV
E6 and E7 proteins target important cellular growth regu-
latory circuits among them the p53 and retinoblastoma
tumor suppressors, respectively. In addition, E6/E7
expression is a driving force for malignant progression
through induction of genomic instability. Hence, high-
risk HPVs are the first-ever identified, necessary and
molecularly defined causative agents of a major human
cancer.
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